ORAL COMMUNICATION 4: Amino-acid and neurotransmitter systems visualized

10:30-10:40 am: Spatial correlation between 68Ga-FAPI uptake, 18F-FET uptake, and MRI makers of aggressiveness in glioblastoma, Amélie Castiaux
10:40-10:50 am: Amino acid PET imaging to monitor mIDH inhibitor treatments in patients with refractory IDH-mutant gliomas, Antoine Verger
10:50-11:00 am: Microvascular physiology in glioma using dynamic [¹⁸F]FET LAFOV PET/CT and Tikhonov model-free deconvolution, Christian Engkebølle
11:00-11:10 am: Longitudinal brain metabolism changes map distinct neuromodulatory networks in autoimmune encephalitis, Federico Massa
11:10-11:20 am: Quantitative [18F]FET PET for Pituitary Neuroendocrine Tumours (PitNET): A Case-Control Study Comparing Pathologically Confirmed functional PitNETs with the normal pituitary gland, Ilanah Pruis
11:20-11:30 am: Uncovering Hidden Prognostic Phenotypes in Glioblastoma: A Composite-Parameter Radiomic Stratification Framework for Equitable AI, Nicholas Laflamme
11:30-11:40 am: In-vivo imaging and quantification of central noradrenaline transporters using [¹¹C]MRB PET/MRI in adults with ADHD and emotional dysregulation, Nicole Mauche
11:40-11:50 am: The confounding effects of microvascular physiology on the uptake and diagnostic accuracy of [18F]fluoroethyl-tyrosine positron emission tomography in patients with glioma, Otto Mølby Henriksen
11:50am-12:00 pm: Enhancing PitNET Diagnosis: The Role of [18F]FET PET, Valerie De Meulenaere